Tong-Chuan He to Immunotherapy
This is a "connection" page, showing publications Tong-Chuan He has written about Immunotherapy.
Connection Strength
0.095
-
PIKfyve, expressed by CD11c-positive cells, controls tumor immunity. Nat Commun. 2024 Jun 28; 15(1):5487.
Score: 0.040
-
Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy. Proc Natl Acad Sci U S A. 2023 Dec 05; 120(49):e2314416120.
Score: 0.038
-
LIGHT delivery to tumors by mesenchymal stem cells mobilizes an effective antitumor immune response. Cancer Res. 2012 Jun 15; 72(12):2980-9.
Score: 0.017